Innate Pharma (IPHA) Non-Current Debt (2017 - 2026)
Innate Pharma (IPHA) posted Non-Current Debt of $10.94 million for the quarter ended Jun 30, 2026, down 46.6% from $20.48 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Non-Current Debt (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma's Non-Current Debt came in at $15.56 million, down 35.5% from the prior year.
- Annual Non-Current Debt has declined for three consecutive years, with a five-year compound annual growth rate of -4.3% (years ended Dec 2020 to Dec 2025).
- In prior years, Innate Pharma's Non-Current Debt was $24.12 million in the year ended Dec 31, 2024 (-44.1%), $43.15 million in the year ended Dec 31, 2023 (-3.1%), $44.53 million in the year ended Dec 31, 2022 (+188.3%) and $15.45 million in the year ended Dec 31, 2021 (-20.2%).
- The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Non-Current Debt since the quarter ended Dec 31, 2018.
- The strongest year-over-year quarter for Non-Current Debt in the past five years was the quarter ended Jun 30, 2023, with growth of 187.8%; the weakest was the quarter ended Jun 30, 2026, with a decline of 46.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Innate Pharma | 159.32 Mn | 159.32 Mn | - | 10.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.94 Mn |
| Dec 31, 2025 | 16.03 Mn |
| Jun 30, 2025 | 20.48 Mn |
| Dec 31, 2024 | 23.81 Mn |
| Jun 30, 2024 | 28.62 Mn |
| Dec 31, 2023 | 33.31 Mn |
| Jun 30, 2023 | 38.46 Mn |
| Dec 31, 2022 | 40.96 Mn |
| Jun 30, 2022 | 13.36 Mn |
| Dec 31, 2021 | 15.45 Mn |
| Jun 30, 2021 | 17.44 Mn |
| Dec 31, 2020 | 20.20 Mn |
| Jun 30, 2020 | 16.78 Mn |
| Dec 31, 2019 | 18.37 Mn |
| Dec 31, 2018 | 3.62 Mn |
| Dec 31, 2017 | 5.32 Mn |
API Access
Innate Pharma Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();